The Nickles Group, LLC
The Nickles Group, LLC filed a Q3 report for Johnson & Johnson Services, Inc. on October 19, 2026, reporting $80,000 in lobbying income.
Lobbying for Johnson & Johnson Services, Inc. · Healthcare company.
Issues related to mental health. Monitored Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization. Issues related to pharmacy benefit management reforms, including alternative funding programs. Monitored issues related to healthcare workforce shortages. Issues related to drug pricing. Issues related to ingredient safety.
Implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Issues related to pharmacy benefit management reforms. Monitored issues related to Medicare physician payment. Issues related to Most Favored Nation drug pricing. Issues related to access of medical devices. Issues related to payments for medical devices, including complexity adjustment criteria.
Monitor implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes.
Issues related to litigation reform.
Issues related to tariffs.
H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act, as it relates to right to repair, and the ability of government contractors to pay dividends and buy back stocks.